Related Experiment Video
Updated: Jun 20, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
A Periaortitis Patient Who Succumbed to COVID-19 While Undergoing Systemic Steroid Therapy: A Case Report and
Ammar Abu Baker1, Qusai Aljarrah1, Mohammad Asim Eyadeh1
1Department of General and Vascular Surgery, King Abdullah University Hospital (KAUH), Jordan University of Science and Technology, Irbid, Jordan.
Insights
This case report highlights the risks of systemic corticosteroids in patients with periaortitis who contract COVID-19. The study emphasizes the need for updated guidelines on managing steroid-dependent patients with inflammatory aortic conditions during the pandemic.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Rheumatology
Background:
- Periaortitis is a rare inflammatory condition affecting the abdominal aorta, typically in middle-aged men.
- Management strategies for periaortitis patients with COVID-19, particularly regarding steroid therapy, are not well-established.
- Steroids have anti-inflammatory benefits but also immunosuppressive risks, creating a complex balance in COVID-19 patients.
Observation:
- A 62-year-old man with autoimmune periaortitis was treated with high-dose corticosteroids (35 mg prednisolone/d).
- He later developed severe COVID-19 (SARS-CoV-2 infection) with respiratory failure and sepsis.
- The patient unfortunately died 44 days after readmission to the ICU.
Findings:
- The case illustrates the potential dangers of maintaining high-dose steroid therapy in periaortitis patients who contract SARS-CoV-2.
- The immunosuppressive effects of corticosteroids may exacerbate COVID-19 outcomes.
Implications:
- There is a critical need for international consensus and updated guidelines for managing steroid-dependent patients with inflammatory aortic conditions during COVID-19.
- Further research and comprehensive analysis of outcomes are essential for these vulnerable patients.
Abstract:
BACKGROUND Periaortitis is an inflammatory condition that typically involves the infrarenal portion of the abdominal aorta. It is a rare disease usually occurring in middle-aged men. Coronavirus disease-2019 (COVID-19) is caused by the SARS-CoV-2 virus. The published literature on the management of steroid therapy in patients with periaortitis and infected with SARS-CoV-2 is lacking. The balance between the indispensable anti-inflammatory properties of steroids and their adverse immunosuppressive characteristics remains unclear in the current COVID-19 scenario, and most of the current practices in managing potentially autoimmune aortic conditions are extrapolated from patients with rheumatological disorders contracting COVID19 while undergoing maintenance steroid therapy. CASE REPORT This report describes the case of a 62-year-old man who presented with nonspecific lower abdominal pain, unremarkable clinical exam, significantly elevated CRP level, and positive antinuclear antibody test. A CT scan showed mild aortic aneurysmal dilatation with periaortic soft tissue thickening, and a PET scan confirmed the finding, showing active abdominal periaortitis. Accordingly, he was diagnosed with autoimmune periaortitis and was maintained on a high dose of systemic corticosteroids (35 mg prednisolone/d). Eight weeks later, he was readmitted to the intensive care unit with worsening respiratory symptoms due to SARS-CoV-2 infection confirmed by PCR test, and unfortunately died 44 days later due to COVID-19-induced respiratory failure and sepsis. CONCLUSIONS The lack of an international consensus on the management of SARS-CoV-2-positive, steroid-dependent patients with serious inflammatory aortic conditions mandates further investigations and thoughtful review of the guidelines for the management of steroid-dependent patients contracting SARS-CoV-2 infection. Additionally, a comprehensive analysis of the outcomes of these patients is essential.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Myocarditis III: Medical Management
Pericarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management

